Literature DB >> 16278052

Would blockage of cytokines improve the outcome of pancreatic islet transplantation?

Mahsa M Amoli1, Bagher Larijani.   

Abstract

It has been estimated that up to 60% of pancreatic islet tissue undergoes apoptosis within the first several days post-transplantation. This strongly suggests the involvement of an inflammatory event other than alloantigen-specific immune reaction following islet transplantation which contributes to partial destruction of grafts. Inflammatory cytokines including IL-1beta, TNF-alpha and IFN-gamma are implicated in the pancreatic islet beta-cell death and functional loss during autoimmune diabetes and also seem to be involved in early loss of islet mass in islet transplantation. Inflammatory cytokines and free oxygen radicals released in situ could cause apoptosis and the functional impairment of islets after islet transplantation and graft failure. It can be hypothesized that preventing destruction of transplanted islets using cytokine blockade could be helpful in improving islet transplantation outcome. Several approaches have been made based on this hypothesis to examine the effect of inflammatory blockade on the islets survival and functional islet mass. Further investigations are required to identify most efficient way for block of cytokine-induced damage in pancreatic islets transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278052     DOI: 10.1016/j.mehy.2005.08.057

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  10 in total

Review 1.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

Review 2.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

3.  Bilirubin protects grafts against nonspecific inflammation-induced injury in syngeneic intraportal islet transplantation.

Authors:  Huaqiang Zhu; Jizhou Wang; Hongchi Jiang; Yong Ma; Shangha Pan; Shiva Reddy; Xueying Sun
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

4.  c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.

Authors:  J L Varona-Santos; A Pileggi; R D Molano; N Y Sanabria; A Ijaz; M Atsushi; H Ichii; R L Pastori; L Inverardi; C Ricordi; A Fornoni
Journal:  Diabetologia       Date:  2008-10-14       Impact factor: 10.122

5.  Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation.

Authors:  J A SoRelle; T Itoh; H Peng; M A Kanak; K Sugimoto; S Matsumoto; M F Levy; M C Lawrence; B Naziruddin
Journal:  Diabetologia       Date:  2013-01-15       Impact factor: 10.122

6.  Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation.

Authors:  Jing Su; Bi-Huang Hu; William L Lowe; Dixon B Kaufman; Phillip B Messersmith
Journal:  Biomaterials       Date:  2009-09-25       Impact factor: 12.479

7.  St. John's wort extract and hyperforin protect rat and human pancreatic islets against cytokine toxicity.

Authors:  Michela Novelli; Pascale Beffy; Marta Menegazzi; Vincenzo De Tata; Luisa Martino; Anna Sgarbossa; Svetlana Porozov; Anna Pippa; Matilde Masini; Piero Marchetti; Pellegrino Masiello
Journal:  Acta Diabetol       Date:  2014-02       Impact factor: 4.280

8.  Effect of genistein on expression of pancreatic SIRT1, inflammatory cytokines and histological changes in ovariectomized diabetic rat.

Authors:  Hadi Yousefi; Alireza Alihemmati; Pouran Karimi; Mohammad Reza Alipour; Parisa Habibi; Nasser Ahmadiasl
Journal:  Iran J Basic Med Sci       Date:  2017-04       Impact factor: 2.699

9.  Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway.

Authors:  Ji-Hyun Lee; Mi-Young Song; Eun-Kyung Song; Eun-Kyung Kim; Woo Sung Moon; Myung-Kwan Han; Jin-Woo Park; Kang-Beom Kwon; Byung-Hyun Park
Journal:  Diabetes       Date:  2008-11-13       Impact factor: 9.461

10.  Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.

Authors:  Taisuke Matsuoka; Gumpei Yoshimatsu; Naoaki Sakata; Ryo Kawakami; Tomoko Tanaka; Teppei Yamada; Yoichiro Yoshida; Suguru Hasegawa; Shohta Kodama
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.